Opportunity Information: Apply for 7200AA22APS00002 03
Apply for 7200AA22APS00002 03
- The Agency for International Development in the health sector is offering a public funding opportunity titled "PROPEL Youth and Gender (Round 3): Promoting Results and Outcomes through Policy and Economic Levers" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2023-01-17.
- Applicants must submit their applications by 2023-02-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $20,000,000.00 in funding.
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
PROPEL Youth and Gender (Round 3): Promoting Results and Outcomes through Policy and Economic Levers is a USAID grant opportunity issued as a specific round under an existing, broader Annual Program Statement (APS). That means applicants are expected to read and follow two connected sets of documents: the Round 3 call itself and the full PROPEL APS (No. 7200AA22APS00002) posted on Grants.gov. The Round 3 notice emphasizes that many core rules and requirements are not repeated in the round-specific write-up, so the APS contains key details that still govern how to apply, who can apply, and how submissions will be reviewed.
This round (No. 7200AA22APS00002-03) is focused on improving the enabling environment for family planning and reproductive health (FP/RH). In practical terms, the round is looking for concept papers that address the policy and systems conditions that shape whether FP/RH services can be delivered effectively, sustained financially, and accessed equitably. A major theme is integration: USAID wants approaches that strengthen FP/RH and also promote its integration with HIV/AIDS programming and maternal and child health (MCH) services. Rather than concentrating only on direct service delivery, the emphasis is on upstream levers that can change how programs are supported, governed, and scaled.
The technical focus for Round 3 is policy, advocacy, financing, and governance (PAFG), with particular attention to youth and adolescents and to gender equity. The intent is to support work that improves laws, regulations, strategies, budget decisions, accountability mechanisms, and advocacy efforts so that young people can access appropriate FP/RH information and services, and so that gender-related barriers are reduced. Concept papers should therefore be oriented toward reforms and system improvements, such as strengthening national or subnational policies, improving financing approaches and resource allocation, building governance and coordination structures, and supporting advocacy that advances equitable FP/RH outcomes for adolescents and other youth populations.
USAID expects to make one award under this round, and the funding instrument will be a cooperative agreement. A cooperative agreement typically indicates that USAID anticipates substantial involvement in the activity during implementation (for example, collaboration on technical direction, learning, or coordination), compared with a standard grant. The opportunity is categorized as discretionary and falls under the health funding activity area, with CFDA listing 98.001. The listed award ceiling is USD 20,000,000, signaling a potentially large-scale effort, although the actual award amount would depend on the final negotiated scope and budget.
The application requested at this stage is a concept paper submission rather than a full proposal, consistent with many APS processes that use concept papers to identify the strongest ideas before inviting more detailed applications. Eligibility is not fully restated in the Round 3 notice; applicants are directed to the full PROPEL APS for general eligibility rules. However, the round notice also states that additional eligibility information specific to Round 3 appears in Section III of the Round 3 Call for Concept Papers, so prospective applicants need to check both the APS and the Round 3 section to confirm they meet all requirements.
Key administrative details from the listing include the opportunity number (7200AA22APS00002-03), an original closing date of February 10, 2023, and a creation date of January 17, 2023. The eligible applicants field is shown as "Others," which usually signals that eligibility may extend beyond a single narrow applicant category, but the definitive eligibility criteria are in the APS and the round-specific eligibility section. Overall, the opportunity is aimed at organizations capable of shaping and strengthening FP/RH enabling environments through PAFG approaches that improve adolescent and youth outcomes and advance gender equity, while also promoting better integration of FP/RH with HIV/AIDS and MCH efforts.
FAQs: PROPEL Youth and Gender (Round 3) - USAID (7200AA22APS00002-03)
What is PROPEL Youth and Gender (Round 3)?
PROPEL Youth and Gender (Round 3) is a USAID grant opportunity focused on improving the enabling environment for family planning and reproductive health (FP/RH), with a strong emphasis on youth and adolescents and on advancing gender equity. The round seeks concept papers that address policy and systems conditions that affect how FP/RH services are delivered, financed, governed, sustained, and accessed equitably.
Is this opportunity a standalone funding announcement?
No. This is a specific round issued under an existing, broader Annual Program Statement (APS). Applicants are expected to follow both the Round 3 Call for Concept Papers and the full PROPEL APS (No. 7200AA22APS00002) posted on Grants.gov. The round notice highlights that many core requirements are not repeated in the round-specific write-up, so the APS remains controlling for many application and review requirements.
What is the official opportunity number for Round 3?
The opportunity number is 7200AA22APS00002-03.
What is the underlying APS number applicants must also follow?
The underlying APS number is 7200AA22APS00002.
What is USAID trying to accomplish through this round?
This round aims to improve the enabling environment for FP/RH by focusing on upstream policy and systems levers that shape program effectiveness, financial sustainability, governance, and equitable access. The intent is to support reforms and improvements that help young people access appropriate FP/RH information and services and reduce gender-related barriers.
What technical areas does Round 3 focus on?
The technical focus is policy, advocacy, financing, and governance (PAFG). Concept papers are expected to align with PAFG approaches, such as strengthening policies and regulations, improving financing and resource allocation, building governance and coordination structures, and supporting advocacy efforts tied to equitable FP/RH outcomes for adolescents and youth.
Does this round prioritize any specific populations?
Yes. The round places particular attention on youth and adolescents and on gender equity, with the goal of improving FP/RH outcomes for young people and reducing gender-related barriers to access.
Is integration with other health areas part of the expectation?
Yes. A major theme is integration. USAID is looking for approaches that strengthen FP/RH while also promoting integration with HIV/AIDS programming and maternal and child health (MCH) services.
Is USAID looking for direct service delivery projects?
The emphasis in Round 3 is not on direct service delivery alone. It is oriented toward upstream levers that change how FP/RH programs are supported, governed, financed, coordinated, and scaled, including improvements to policies, systems, and accountability mechanisms.
What type of application is required at this stage?
The round requests a concept paper submission rather than a full proposal. This is consistent with APS processes that use concept papers to identify the strongest ideas before inviting more detailed applications.
How many awards does USAID expect to make under this round?
USAID expects to make one award under this round.
What type of award instrument will be used?
The funding instrument is a cooperative agreement.
What does it mean that the award will be a cooperative agreement?
A cooperative agreement typically indicates that USAID anticipates substantial involvement during implementation, such as collaboration on technical direction, learning, or coordination, compared with a standard grant.
What is the maximum funding amount available?
The listed award ceiling is USD 20,000,000. The actual award amount would depend on the final negotiated scope and budget.
What is the funding category and activity area for this opportunity?
The opportunity is categorized as discretionary and falls under the health funding activity area.
What CFDA listing is associated with this opportunity?
The listing includes CFDA 98.001.
Who is eligible to apply?
The Round 3 notice does not fully restate eligibility. It directs applicants to the full PROPEL APS for general eligibility rules, and it states that additional eligibility information specific to Round 3 is provided in Section III of the Round 3 Call for Concept Papers. The listing shows eligible applicants as "Others," but the definitive criteria are in the APS and the Round 3 eligibility section.
Where can applicants find the complete rules and requirements?
Applicants should consult two sources: (1) the Round 3 Call for Concept Papers (including Section III for round-specific eligibility information) and (2) the full PROPEL APS (No. 7200AA22APS00002) on Grants.gov. The round notice emphasizes that many core requirements are only found in the APS.
What are examples of the kinds of changes or results concept papers should aim for?
Based on the round description, concept papers should be oriented toward enabling-environment improvements such as stronger laws, regulations, and strategies; improved budget decisions and resource allocation; stronger accountability mechanisms; better governance and coordination structures; and advocacy efforts that advance equitable FP/RH outcomes for adolescents and youth, including reducing gender-related barriers.
What is the closing date listed for this opportunity?
The original closing date listed is February 10, 2023.
What is the creation date listed for this opportunity?
The creation date listed is January 17, 2023.
Why does the Round 3 notice say the APS still governs the application?
Because the round-specific notice does not repeat many core rules and requirements. The APS contains key details that still govern how to apply, who can apply, and how submissions will be reviewed, so applicants are expected to rely on both documents together.
What is the overall emphasis of this round in plain terms?
The overall emphasis is on improving the systems and policy environment that determine whether FP/RH services for young people can be delivered effectively, sustained financially, integrated with related health programs (HIV/AIDS and MCH), and accessed equitably, with gender equity built into the approach.
Browse more opportunities from the same category: Health
Next opportunity: Comprehensive Community Prevention and Continuum of Care (C4) Project
Previous opportunity: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 7200AA22APS00002 03
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (7200AA22APS00002 03) also looked into and applied for these:
| Funding Opportunity |
|---|
| AHRQ Small Research Projects to Advance the Science of Primary Care (R03) Apply for PA 23 115 Funding Number: PA 23 115 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) Apply for RFA MD 23 002 Funding Number: RFA MD 23 002 Agency: National Institutes of Health Category: Health Funding Amount: $295,924 |
| Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) Apply for PAR 22 262 Funding Number: PAR 22 262 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Team Science Approaches Integrating Experimental and Computational Brain Aging Models (R21/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 018 Funding Number: RFA AG 24 018 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed) Apply for PAR 23 089 Funding Number: PAR 23 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Social and Behavior Change Apply for RFI 72052123R00004 Funding Number: RFI 72052123R00004 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: Case Dependent |
| Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) Apply for RFA EB 23 001 Funding Number: RFA EB 23 001 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Comprehensive Community Prevention and Continuum of Care (C4) Project Apply for RFI 674 23 COMPREHENSIVECAREBOTS Funding Number: RFI 674 23 COMPREHENSIVECAREBOTS Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) Apply for PAR 23 111 Funding Number: PAR 23 111 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) Apply for PAR 23 077 Funding Number: PAR 23 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 23 035 Funding Number: PAR 23 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium for Food Allergy Research: Leadership Center (UM1 Clinical Trial Required) Apply for RFA AI 22 077 Funding Number: RFA AI 22 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required) Apply for RFA AI 22 076 Funding Number: RFA AI 22 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required) Apply for PAR 23 090 Funding Number: PAR 23 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Coordinating Center on the Exposome and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD): Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed) Apply for RFA AG 24 011 Funding Number: RFA AG 24 011 Agency: National Institutes of Health Category: Health Funding Amount: $5,000,000 |
| Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clinical Trial Optional) Apply for RFA NS 24 001 Funding Number: RFA NS 24 001 Agency: National Institutes of Health Category: Health Funding Amount: $4,700,000 |
| Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 008 Funding Number: RFA AI 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $1,400,000 |
| Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) Apply for RFA MD 23 008 Funding Number: RFA MD 23 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) Apply for RFA MD 23 007 Funding Number: RFA MD 23 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Networking/Infrastructure Project for Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging Related Outcomes, and Prospects for Translation (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 020 Funding Number: RFA AG 24 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "7200AA22APS00002 03", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.